Pharmaceutical Product Supply – METHOCARBAMOL TABLETS

The contract entails the supply of FDA-compliant methocarbamol tablets adhering to stringent military and federal pharmaceutical standards, ensuring quality, safety, and consistency for authorized federal use. All products must meet exacting requirements for labeling, packaging, and traceability to support full end-to-end accountability across the defense supply chain. The tablets are intended for distribution through Department of Defense channels and must comply with all regulatory and operational specifications mandated by the Defense Logistics Agency. This subcontract, classified under NAICS code 325412, is managed by the Department of Defense through the Defense Logistics Agency and is tied to contract SPE2DP26F7705. Though no specific delivery location or point of contact is listed, the performance is scoped to meet federal military pharmaceutical logistics demands, emphasizing compliance, documentation integrity, and secure handling protocols. The solicitation was posted on July 15, 2026, and is active under the DIBBS system for tracking and award administration.